NCT07031986

Brief Summary

The goal of this clinical trial is to evaluate the efficacy of bronchial blockers and double-lumen tubes in achieving one-lung ventilation in obese patients undergoing lung resections. The primary question it aims to answer is: • Is intraoperative hypoxia significantly different depending on the device used? Researchers will compare the use of bronchial blockers and double-lumen tubes to assess differences in efficacy and safety. Participants will not be required to perform any tasks.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 15, 2024

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 11, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 22, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

June 22, 2025

Status Verified

June 1, 2025

Enrollment Period

1.6 years

First QC Date

June 11, 2025

Last Update Submit

June 19, 2025

Conditions

Keywords

one-lung ventilationlung resectionbronchial blockerdouble-lumen tube

Outcome Measures

Primary Outcomes (1)

  • Hypoxia

    While its definition is somewhat arbitrary, the investigators consider hypoxia as SpO₂ \< 90%, while maintaining FiO₂ = 1.0, in accordance to our hospital guidelines.

    Intraoperative (both from anesthetic induction to one-lung ventilation, and during one-lung ventilation)

Secondary Outcomes (21)

  • Lung collapse

    Intraoperative

  • Surgical visualization

    Intraoperative

  • Insertion time of the ventilation device

    Intraoperative

  • Repositioning of the ventilation device

    Intraoperative

  • Ventilation device change

    Intraoperative

  • +16 more secondary outcomes

Other Outcomes (22)

  • Sex

    Preoperative

  • Age

    Preoperative

  • Obesity

    Preoperative

  • +19 more other outcomes

Study Arms (2)

Bronchial Blocker

EXPERIMENTAL

Patients undergoing lung resection who receive one-lung ventilation using a bronchial blocker.

Device: One-Lung Ventilation with Bronchial Blocker

Double-Lumen Tube

EXPERIMENTAL

Patients undergoing lung resection who receive one-lung ventilation using a double-lumen tube.

Device: One-Lung ventilation with Double-Lumen Tube

Interventions

To achieve the required one-lung ventilation during lung resection, patients will be managed with a double-lumen tube.

Double-Lumen Tube

To achieve the required one-lung ventilation during lung resection, patients will be managed with a bronchial blocker.

Bronchial Blocker

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI ≥ 30 kg/m2
  • Diagnostic or clinical suspicion of lung cancer
  • Lung resection surgery (lobectomy, segmentectomy or wedge resection) by VATS or thoracotomy, requiring one-lung ventilation.
  • Use of bronchial blocker or double-lumen tube for one-lung ventilation.

You may not qualify if:

  • Patients with evident anatomic alterations, in which double-lumen tubes may be contraindicated.
  • Emergency surgeries.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Son Espases

Palma de Mallorca, Balearic Islands, 07120, Spain

RECRUITING

MeSH Terms

Interventions

One-Lung Ventilation

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeutics

Study Officials

  • Paulo Andrés Cano, MD

    Hospital Son Espases

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Paulo Andrés Cano, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patients do not know which device will be used during their surgery, as is typical in routine clinical practice.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Patients will be randomly allocated to one of two one-lung ventilation groups. The study focuses on intraoperative ventilation during lung resection; therefore, no follow-up is planned. The study concludes for each patient at the end of the surgery.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 11, 2025

First Posted

June 22, 2025

Study Start

August 15, 2024

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

June 22, 2025

Record last verified: 2025-06

Locations